These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33154775)

  • 1. The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.
    Zhong F; Lu HP; Chen G; Dang YW; Zhang XG; Liang Y; Li MX; Li GS; Chen XY; Yao YX; Qin YY; Mo M; Zhang KL; Ding H; Huang ZG; Wei ZX
    Oncol Lett; 2020 Dec; 20(6):377. PubMed ID: 33154775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of the Interleukin 24 mRNA Level in Head and Neck Squamous Cell Carcinoma and Its Subgroups: An In Silico Investigation.
    Qiu LL; Zhang XG; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Huang SN; Tang XZ; Chen XX; Wei HY; Wu HY
    J Oncol; 2020; 2020():7042025. PubMed ID: 33014054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neck.
    Ichinose J; Shinozaki-Ushiku A; Nagayama K; Nitadori JI; Anraku M; Fukayama M; Nakajima J; Takai D
    Lung Cancer; 2016 Oct; 100():96-101. PubMed ID: 27597287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
    Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
    Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
    Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
    Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.
    Huang Q; Yu GP; McCormick SA; Mo J; Datta B; Mahimkar M; Lazarus P; Schäffer AA; Desper R; Schantz SP
    Genes Chromosomes Cancer; 2002 Jun; 34(2):224-33. PubMed ID: 11979556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Dai Y; Liu Y; Tian X; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of higher transient receptor potential melastatin 8 expression with higher tumor histologic grades, lymph node metastasis, risk factors, and worse survival in patients with head and neck squamous cell carcinoma.
    Lin NC; Vu Nguyen TH; Shih YH; Chen YH; Shen YW; Chiu KC; Hsia SM; Shieh TM
    J Dent Sci; 2024 Jan; 19(1):492-501. PubMed ID: 38303833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRE11 as a plausible biomarker and prognostic bioindicator for head and neck squamous cell carcinoma.
    Li Z; Zhang Y; Huang X; Gopinath D
    J Stomatol Oral Maxillofac Surg; 2024 Jul; ():101970. PubMed ID: 39032645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
    Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
    J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries.
    Silveira NJ; Varuzza L; Machado-Lima A; Lauretto MS; Pinheiro DG; Rodrigues RV; Severino P; Nobrega FG; ; Silva WA; de B Pereira CA; Tajara EH
    BMC Med Genomics; 2008 Nov; 1():56. PubMed ID: 19014460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of immune cell markers in feline oral squamous cell carcinoma.
    Sparger EE; Murphy BG; Kamal FM; Arzi B; Naydan D; Skouritakis CT; Cox DP; Skorupski K
    Vet Immunol Immunopathol; 2018 Aug; 202():52-62. PubMed ID: 30078599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPINK5 is a Prognostic Biomarker Associated With the Progression and Prognosis of Laryngeal Squamous Cell Carcinoma Identified by Weighted Gene Co-Expression Network Analysis.
    Liu J; Zhao J; Xu J; Sun Q; Qin X; Chen G; Gao T; Bai G; Guo Z
    Evol Bioinform Online; 2022; 18():11769343221077118. PubMed ID: 35140453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas.
    Gandini NA; Fermento ME; Salomón DG; Blasco J; Patel V; Gutkind JS; Molinolo AA; Facchinetti MM; Curino AC
    Exp Mol Pathol; 2012 Oct; 93(2):237-45. PubMed ID: 22580187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.
    Jin Y; Yang Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31324732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.